Message from APIN CEO
Dr. Prosper Okonkwo
Chief Executive Officer (CEO), APIN
It is very heartening to see APIN, the organization that started as a small project of the Harvard School of Public Health, focused on prevention and PMTCT only, evolve into a leading public health organization in Nigeria. Throughout our evolution, from APIN to APIN Plus to AIDS Prevention Initiative in Nigeria and now APIN Public Health Initiatives, we have been guided by our mission “providing cutting edge, innovative & sustainable approaches to address diseases of public health importance through effective program management, service delivery, capacity building, research, strategic information & advocacy in partnership with other stakeholders”. Our strategic alliances, partnerships, technical assistance approach and service delivery models have prioritized building sustainable systems that our partners can run without donor support, whether they be government agencies, civil society organizations or hospitals.
As one of the pioneer non-governmental organizations and a key stakeholder in the national HIV response, we have built infrastructural and organizational capacity that allows us understand the changing public health landscape in Nigeria and rapidly tailor interventions to meet the requirements of the different constituencies and actors.
Now, in our 17th year of operations, we are excited to look beyond the HIV/AIDS sphere in line with our vision of being the lead public health NGO in Nigeria and Africa committed to reduced disease burden and impact mitigation. We are ready and well positioned to contribute meaningfully to other areas of public health importance in Nigeria and beyond, by leveraging on our team of highly diversified public health professionals, clinicians, organizational development experts and robust management systems.
APIN Public Health Initiatives Ltd./Gte, formerly known as AIDS Prevention Initiative in Nigeria is a non-governmental organization registered with the Nigerian Corporate Affairs Commission (CAC). APIN has built a strong partnership with the Nigerian Government, which is memorialized through a memorandum of understanding (MOU) with the National Planning Commission. APIN is a leading Nigerian organization in the provision of prevention, care and treatment services to patients with HIV/AIDS, Tuberculosis; Malaria; Reproductive Health; Family Planning; Maternal, Newborn and Child Health, and other non-communicable diseases of public health significance. Its operating experience in Nigeria dates back to 2000, when the Harvard School of Public Health (HSPH) initiated HIV/AIDS research and prevention initiatives in Nigeria, with funding from the Bill & Melinda Gates Foundation. In 2004, the HSPH project started implementing HIV/AIDS prevention, care and treatment programs with support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). These activities culminated in the establishment of APIN as an independent NGO in 2007, with the aim of building local capacity and sustainability of HIV/AIDS and other diseases programming in Nigeria. APIN got its first grant of $1.7m as an independent grantee in 2008, while still operating as a sub recipient to HSPH till 2012. Presently, APIN operates as a direct implementing partner to CDC following completion of a 5-year transition from Harvard in 2012. This transition was in line with the US Government’s goal of transitioning programs to local indigenous organizations. In the eleven (11) years since its operations as an implementing partner of the CDC, APIN has managed a cumulative budget of more than $120m, a reflection of the growing confidence of the USG that APIN has built strong enough systems to operate as an independent implementing partner of US funds. In addition to the US funded activities, APIN is currently implementing grants from other major donors which has enhanced its opportunities to diversify its funding base in the wider public health arena as part of its response to current health challenges and its overall sustainability plan. Such grants currently being implemented by APIN include an NIH/Fogarty International Building Research and Innovation in Nigeria’s Science (BRAINS) grants with University of Lagos College of Medicine, Global Fund HIV/AIDS projects as sub recipient (SR) in Lagos State, The Save One Million Life Program for Result (SOML-PforR) from the Nigerian government through Federal Ministry of Health and Nigeria State Health Investment Project (NSHIP), covering three states in the North East from the National Primary Health Care Development Agency (NPHCDA).
Apart from its contribution to evidence-based HIV prevention in the country, APIN is also one of the pioneers in the provision of comprehensive HIV/AIDS care in Nigeria. It currently supports the Federal Government of Nigeria to provide ARV care and treatment directly as a USG implementing partner to more than 250,000 patients (representing approximately 25% of patients on ART in Nigeria) in over 570 comprehensive treatment sites in eight (8) states. APIN has also placed close to 13,000 patients on treatment under the Global Fund project in Lagos. These clinics are equipped with state-of-the-art laboratories with capabilities for diagnosis and monitoring of HIV including CD4, viral load, DNA PCR and drug resistance monitoring (DRM). Similar giant strides have been made in prevention, systems strengthening, as well as in human and infrastructure capacity development efforts. It has a widespread network of service providers, communities, researchers and persons living with HIV and AIDS support groups in eight (8) states in Nigeria. APIN has a purposeful, exemplary and result-oriented leadership, committed and hardworking human resources and a broad-based support of collaborators in Nigeria and the United States. It essentially inherited the same dedicated team that has worked on the Harvard program.
To be the leading Public Health NGO committed to reduced disease burden and impact mitigation in Nigeria and Africa.
To provide cutting-edge, innovative & sustainable approaches to address the disease of public health importance through effective program management, service delivery, capacity building, research, strategic information & advocacy in partnership with other stakeholders.